Dimeric peptides of the C-terminal region of CXCL14 function as CXCL12 inhibitors

FEBS Letters

Volumn 587, Issue 23, 2013, Pages 3770-3775

  Tanegashima, Kosuke ^a   Tsuji, Kohei ^b   Suzuki, Kenji ^a,c   Shigenaga, Akira ^b   Otaka, Akira ^b   Hara, Takahiko ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Helix; CXCL12; CXCL14; CXCR4

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CXCL14 CHEMOKINE; DIMER; OXIME; PROTEIN INHIBITOR; STROMAL CELL DERIVED FACTOR 1;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CONTROLLED STUDY; DIMERIZATION; DISULFIDE BOND; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; SOLUBILITY;

Α-HELIX; CD; CIRCULAR DICHROISM; CXCL12; CXCL14; CXCR4; FACS; FLUORESCENT ACTIVATED CELL SORTING; TFA; TRIFLUOROACETIC ACID;

CELL LINE, TUMOR; CELL MEMBRANE; CHEMOKINE CXCL12; CHEMOKINES, CXC; DIMERIZATION; DISULFIDES; HUMANS; MUTATION; PEPTIDES; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT;

EID: 84888014682     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.10.017     Document Type: Article

References (21)

1. J.M. Busillo, and J.L. Benovic Regulation of CXCR4 signaling Biochim. Biophys. Acta 1768 2007 952 963
2. A. Zlotnik, A.M. Burkhardt, and B. Homey Homeostatic chemokine receptors and organ-specific metastasis Nat. Rev. Immunol. 11 2011 597 606
3. F. Balkwill Cancer and the chemokine network Nat. Rev. Cancer 4 2004 540 550
4. B.J. Rollins Chemokines Blood 90 1997 909 928
5. 2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities J. Biol. Chem. 266 1991 23128 23134
6. M.P. Crump, J.H. Gong, P. Loetscher, K. Rajarathnam, A. Amara, F. Arenzana-Seisdedos, J.L. Virelizier, M. Baggiolini, B.D. Sykes, and I. Clark-Lewis Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1 EMBO J. 16 1997 6996 7007
7. C. Blanpain, B.J. Doranz, A. Bondue, C. Govaerts, A. De Leener, G. Vassart, R.W. Doms, A. Proudfoot, and M. Parmentier The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle J. Biol. Chem. 278 2003 5179 5187
8. Y. Kofuku, C. Yoshiura, T. Ueda, H. Terasawa, T. Hirai, S. Tominaga, M. Hirose, Y. Maeda, H. Takahashi, Y. Terashima, K. Matsushima, and I. Shimada Structural basis of the interaction between chemokine stromal cell-derived factor-1/CXCL12 and its G-protein-coupled receptor CXCR4 J. Biol. Chem. 284 2009 35240 35250
9. K. Tanegashima, K. Suzuki, Y. Nakayama, K. Tsuji, A. Shigenaga, A. Otaka, and T. Hara CXCL14 is a natural inhibitor of the CXCL12-CXCR4 signaling axis FEBS Lett. 587 2013 1731 1735
10. F.C. Peterson, J.A. Thorpe, A.G. Harder, B.F. Volkman, and S.R. Schwarze Structural determinants involved in the regulation of CXCL14/BRAK expression by the 26S proteasome J. Mol. Biol. 363 2006 813 822
11. K. Tanegashima, K. Suzuki, Y. Nakayama, and T. Hara Antibody-assisted enhancement of biological activities of CXCL14 in human monocytic leukemia-derived THP-1 cells and high fat diet-induced obese mice Exp. Cell Res. 316 2010 1263 1270
12. K. Tsuji, A. Shigenaga, Y. Sumikawa, K. Tanegashima, K. Sato, K. Aihara, T. Hara, and A. Otaka Application of N-C- or C-N-directed sequential native chemical ligation to the preparation of CXCL14 analogs and their biological evaluation Bioorg. Med. Chem. 19 2011 4014 4020
13. Y. Hagiwara The method to measure good OD spectra PSSJ Arch. 1 2008 e002
14. N.F. Neel, E. Schutyser, J. Sai, G.H. Fan, and A. Richmond Chemokine receptor internalization and intracellular trafficking Cytokine Growth Factor Rev. 16 2005 637 658
15. A. Otaka, M. Nakamura, D. Nameki, E. Kodama, S. Uchiyama, S. Nakamura, H. Nakano, H. Tamamura, Y. Kobayashi, M. Matsuoka, and N. Fujii Remodeling of gp41-C34 peptide leads to highly effective inhibitors of the fusion of HIV-1 with target cells Angew. Chem.; Int. Ed. 41 2002 2937 2940
16. A. Dirksen, and P.E. Dawson Rapid oxime and hydrazone ligations with aromatic aldehydes for biomolecular labeling Bioconjugate Chem. 19 2008 2543 2548
17. 15N) NMR assignments and solution structure of the monocyte chemoattractant protein-1 (MCP-1) dimer Biochemistry 35 1996 6569 6584
18. W.D. Holmes, T.G. Consler, W.S. Dallas, W.J. Rocque, and D.H. Willard Solution studies of recombinant human stromal-cell-derived factor-1 Protein Expression Purif. 21 2001 367 377
19. L.J. Drury, J.J. Ziarek, S. Gravel, C.T. Veldkamp, T. Takekoshi, S.T. Hwang, N. Heveker, B.F. Volkman, and M.B. Dwinell Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways Proc. Natl. Acad. Sci. U.S.A. 108 2011 17655 17660
20. G.M. Clore, E. Appella, M. Yamada, K. Matsushima, and A.M. Gronenborn Three-dimensional structure of interleukin 8 in solution Biochemistry 29 1990 1689 1696
21. L.O. Gerlach, R.T. Skerlj, G.J. Bridger, and T.W. Schwartz Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor J. Biol. Chem. 276 2001 14153 14160